Evaluation of a risk score based on dietary and lifestyle factors to target a population at risk in colorectal cancer screening.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
07 2021
Historique:
received: 16 11 2020
revised: 05 03 2021
accepted: 06 03 2021
pubmed: 1 5 2021
medline: 2 2 2022
entrez: 30 4 2021
Statut: ppublish

Résumé

The aim of our study was to assess three risk scores to predict lesions, advanced neoplasia (high-risk adenomas and colorectal cancer (CRC)) and CRC in individuals who participate to colorectal cancer screening. The data of dietary and lifestyle risk factors were carried out during 2 mass screening campaigns in France (2013-2016) and the FOBT result was collected until December 2018. The colonoscopy result in positive FOBT was recovered. Three risk scores (Betés score, Kaminski score and adapted-HLI) were calculated to detect individuals at risk of lesions. The Betés score had an AUROC of 0.63 (95% CI, [0.61-0.66]) for lesions, 0.65 (95% CI, [0.61-0.68]) for advanced neoplasia and 0.65 (95% CI, [0.58-0.72]) for predicting screen-detected CRC. The adapted HLI score had an AUROC of 0.61 (95% CI, [0.58-0.65]) for lesions, 0.61 (95% CI, [0.56-0.65]) for advanced neoplasia and 0.55 (95% CI, [0.45-0.65]) for predicting screen-detected CRC. The Kaminski score had an AUROC of 0.65 (95% CI, [0.63-0.68]) for lesions, 0.65 (95% CI, [0.61-0.68]) for advanced neoplasia and 0.69 (95% CI, [0.62-0.76]) for predicting screen-detected CRC. A simple questionnaire based on CRC risk factors could help general practitioners to identify participants with higher risk of significant colorectal lesions and incite them to perform the fecal occult blood test.

Sections du résumé

BACKGROUND
The aim of our study was to assess three risk scores to predict lesions, advanced neoplasia (high-risk adenomas and colorectal cancer (CRC)) and CRC in individuals who participate to colorectal cancer screening.
METHODS
The data of dietary and lifestyle risk factors were carried out during 2 mass screening campaigns in France (2013-2016) and the FOBT result was collected until December 2018. The colonoscopy result in positive FOBT was recovered. Three risk scores (Betés score, Kaminski score and adapted-HLI) were calculated to detect individuals at risk of lesions.
RESULTS
The Betés score had an AUROC of 0.63 (95% CI, [0.61-0.66]) for lesions, 0.65 (95% CI, [0.61-0.68]) for advanced neoplasia and 0.65 (95% CI, [0.58-0.72]) for predicting screen-detected CRC. The adapted HLI score had an AUROC of 0.61 (95% CI, [0.58-0.65]) for lesions, 0.61 (95% CI, [0.56-0.65]) for advanced neoplasia and 0.55 (95% CI, [0.45-0.65]) for predicting screen-detected CRC. The Kaminski score had an AUROC of 0.65 (95% CI, [0.63-0.68]) for lesions, 0.65 (95% CI, [0.61-0.68]) for advanced neoplasia and 0.69 (95% CI, [0.62-0.76]) for predicting screen-detected CRC.
CONCLUSION
A simple questionnaire based on CRC risk factors could help general practitioners to identify participants with higher risk of significant colorectal lesions and incite them to perform the fecal occult blood test.

Identifiants

pubmed: 33926818
pii: S1590-8658(21)00101-8
doi: 10.1016/j.dld.2021.03.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

900-907

Informations de copyright

Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have nothing to disclose concerning this study.

Auteurs

Carole Vitellius (C)

Department of Hepato-Gastroenterology, University Hospital, 4 rue Larrey, 49933, Angers, France; HIFIH laboratory, UNIV Angers, Université Bretagne Loire, Angers, France.

Sandrine Bertrais (S)

HIFIH laboratory, UNIV Angers, Université Bretagne Loire, Angers, France.

Julie Antier (J)

Department of Hepato-Gastroenterology, University Hospital, 4 rue Larrey, 49933, Angers, France.

Emmanuelle Kesse-Guyot (E)

Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre d'Epidémiologie et Statistiques Sorbonne Paris Cité, Inserm U1153, Inra U1125, Cnam, COMUE Sorbonne Paris Cité, Université Paris 13, Bobigny, France.

Mathilde Touvier (M)

Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre d'Epidémiologie et Statistiques Sorbonne Paris Cité, Inserm U1153, Inra U1125, Cnam, COMUE Sorbonne Paris Cité, Université Paris 13, Bobigny, France.

Nathanaëlle Cornet (N)

Department of Hepato-Gastroenterology, University Hospital, 4 rue Larrey, 49933, Angers, France.

Margot Laly (M)

Department of Hepato-Gastroenterology, University Hospital, 4 rue Larrey, 49933, Angers, France.

Jean-Marie Chrétien (JM)

Department of Hepato-Gastroenterology, University Hospital, 4 rue Larrey, 49933, Angers, France.

Isabelle de Hercé (I)

Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre d'Epidémiologie et Statistiques Sorbonne Paris Cité, Inserm U1153, Inra U1125, Cnam, COMUE Sorbonne Paris Cité, Université Paris 13, Bobigny, France.

Anne-Sophie Banaszuk (AS)

Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre d'Epidémiologie et Statistiques Sorbonne Paris Cité, Inserm U1153, Inra U1125, Cnam, COMUE Sorbonne Paris Cité, Université Paris 13, Bobigny, France.

François-Xavier Caroli-Bosc (FX)

Department of Hepato-Gastroenterology, University Hospital, 4 rue Larrey, 49933, Angers, France; HIFIH laboratory, UNIV Angers, Université Bretagne Loire, Angers, France; CAP-Santé 49, Angers, France. Electronic address: FXCaroli-Bosc@chu-angers.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH